Peptides for immune support: hype vs. what studies show

What did @kristinastout actually say?

Kristina, a nurse practitioner promoting Harmony Wellness Clinic, recommended two injectable peptide products for immune support tied to back-to-school season: thymosin alpha-1 (TA-1) and glutathione. She described TA-1 as boosting T cell activity and helping the body fight "viral, bacterial and fungal diseases," and positioned glutathione as a liver detoxifier that reduces oxidative stress. Both come pre-mixed from a 503A compounding pharmacy, she said, at $200 to $250 for a five-week supply.

It's worth noting upfront that this video is promotional content for her own clinic. She is selling a service. That context matters when evaluating how the science gets presented here.

Does the science back this up?

Partially, but the framing is rosier than the evidence warrants. Thymosin alpha-1 has the most legitimate research behind it, though most of that research involves immunocompromised patients, not healthy adults trying to dodge a school-year cold.

TA-1 is a naturally occurring peptide derived from the thymus gland. It has been studied in sepsis, hepatitis B and C, and cancer patients undergoing chemotherapy. A randomized controlled trial by Romani et al. (2012, Journal of Infectious Diseases) found TA-1 improved immune responses in patients with invasive aspergillosis. A meta-analysis by Wu et al. (2013, Journal of Thoracic Disease) showed it reduced mortality in severe sepsis. These are seriously ill people. Extrapolating that to a healthy person who wants to avoid a rhinovirus is a leap the data does not support.

Glutathione is trickier. It is the body's primary antioxidant, produced endogenously in the liver. Intravenous and injectable glutathione has been studied for specific conditions like Parkinson's disease and acetaminophen toxicity. But robust clinical trial data supporting subcutaneous glutathione injections for immune enhancement in healthy people is thin. The bioavailability of injected glutathione versus oral supplementation is better, but "better than oral" is not the same as "clinically meaningful."

What did they get wrong (or right)?

Let's start with what's defensible. The basic mechanistic claims about TA-1 are not wrong. It does modulate T cell activity. The science on that mechanism is real. Glutathione's role in reducing oxidative stress is also well-established at a biological level. Credit where it's due.

But here's where it gets problematic. Saying TA-1 helps with "finding diseases, including viral, bacterial and fungal diseases" without qualification implies a breadth of immune protection that the clinical evidence in healthy populations simply does not confirm. That's a meaningful overreach.

The detox framing for glutathione is also a red flag. Your liver is not a bucket of toxins waiting to be emptied. "Detoxifying specifically your liver" implies a dysfunction that glutathione is correcting. In people with actual liver disease, glutathione depletion is a documented problem. In a healthy adult, the clinical justification for injectable glutathione as a routine immune booster is not well-supported by randomized trial data.

The 503A compounding pharmacy mention is technically relevant disclosure, but it should come with a clearer caveat: compounded peptides are not FDA-approved drugs. Quality control varies by pharmacy. Reconstituted products sent through the mail carry handling risks that affect potency.

What should you actually know?

If you are immunocompromised, have a chronic infection, or are managing a condition like hepatitis, the conversation about TA-1 or glutathione with a physician is at least grounded in some clinical rationale. That's a different situation than a healthy parent hearing a TikTok nurse practitioner pitch a $450 monthly injection protocol as a back-to-school immune boost.

Thymosin alpha-1 is not approved by the FDA for any indication in the United States. It is available in other countries for specific indications. In the U.S., it exists in a regulatory gray zone, prescribed off-label and compounded. That is not automatically dangerous, but it is not a casual decision either.

Glutathione injections carry their own considerations. A 2011 FDA safety communication flagged concerns about skin-lightening products containing injectable glutathione, noting risks including nerve damage and kidney problems at high doses. The doses used here are likely different, but the point stands: "natural" does not mean risk-free, and "antioxidant" is not a clinical diagnosis.

Before spending $450 on a five-week injection protocol from a telehealth clinic you found on TikTok, it is worth asking what problem is actually being solved. If your immune system is functioning normally, the evidence base for these specific interventions, at these price points, delivered this way, is not strong.